Search bioRxivSearch

Biology subjects

Woollard, K.

Publications and source records attributed to Woollard, K..

2 recordsLinked to original sources

The GPIbα intracellular tail - role in transducing VWF- and Collagen/GPVI-mediated signaling

Synergy between GPIb and GPVI signaling machineries has been suggested previously, however its molecular mechanism remains unclear. We generated a novel GPIb transgenic mouse (GPIb{Delta}sig/{Delta}sig) by CRISPR-Cas9 technology to delete the last 24 residues of the GPIb intracellular tail important for VWF-mediated signaling. GPIb{Delta}sig/{Delta}sig platelets bound VWF normally under flow but formed fewer filopodia on VWF/botrocetin, demonstrating that the deleted region does not affect ligand binding but appreciably impairs VWF-dependent signaling. Notably, while haemostasis was normal in GPIb{Delta}sig/{Delta}sig mice, GPIb{Delta}sig/{Delta}sig platelets exhibited defective responses after collagen-related-peptide stimulation and formed smaller aggregates on collagen-coated microchannels at low and high shears. Flow assays performed with plasma-free blood or in the presence of IIb{beta}3-or GPVI-blockers suggested reduced IIb{beta}3 activation contributes to the phenotype of the GPIb{Delta}sig/{Delta}sig platelets. Together, these results reveal a new role for the intracellular tail of GPIb in transducing both VWF-GPIb and collagen-GPVI signaling events in platelets. Summary statementGPIb and GPVI are two key receptors on the platelet surface. Using a novel transgenic mouse (GPIb{Delta}sig/{Delta}sig) that lacks the last 24 amino acids of the GPIb intracellular tail, we demonstrate the importance of this region not only in transducing signals in response to GPIb binding to VWF, but also for collagen-GPVI-mediated platelet responses revealing previously underappreciated receptor crosstalk between GPIb and GPVI.

cell biology

The association of plasma lipids with white blood cell counts: Results from the Multi-Ethnic Study of Atherosclerosis

Background and aimsPrevious studies have demonstrated that elevated cholesterol results in increased white blood cell counts in mouse models. However, there is insufficient evidence to support this in humans. We, therefore, investigated the relationship of plasma lipids with white blood cell counts (basophils, eosinophils, monocytes, neutrophils and lymphocytes) in the Multi-Ethnic Study of Atherosclerosis (MESA). MethodsThe analysis included 2873 MESA participants at visit 5 with a complete white blood count and differential analysis. The cross-sectional association of total cholesterol, LDL cholesterol, HDL cholesterol and triglyceride levels with different white blood cell counts was analyzed by multivariable linear regression. ResultsAfter adjusting sociodemographic and confounding factors including red blood cells counts, platelet counts, use of lipid-lowering medication, CVD risk factors and other lipid measures, and multiple testing correction, a 1-SD increment in total cholesterol and LDL cholesterol was associated with 2.8% and 2.3% (both p<0.001) lower total white blood cell counts. The same increment in ln-transformed triglyceride levels was associated with 2.3% higher total white blood cell counts, 2.9% higher lymphocyte counts and 2.7% lower monocyte counts (all p<0.001). HDL cholesterol was not associated with any white blood cell counts. Similar results were obtained after excluding participants taking lipid-lowering medication. ConclusionsWhilst significant associations were observed, the heterogenous and modest nature of the relationships between plasma lipid levels and white blood cell populations make it hard to support the hypothesis that lipids are in the causal pathway for leukogenesis.

epidemiology